Paper
22 February 2019 In vivo multiphoton dynamic imaging of the hepatobiliary metabolism in chronic hepatic diseases
Author Affiliations +
Abstract
Intravital multiphoton microscopy was used to study hepatobiliary metabolism in chronic pathologies of the liver. Through the use of the probe molecule 6-carboxyfluorescein diacetate (6-CFDA), the effects of liver fibrosis, fatty liver, and hepatocellular carcinoma on the metabolic capabilities of mouse liver were investigated. After the acquisition of time lapse images, a first order kinetic model was used to calculate rate constant resolved images of various pathologies. It was found the ability of the liver to metabolically process the probe molecules varies among different pathologies, with liver fibrosis and fatty liver disease negatively impacted the uptake, processing, and excretion of molecules.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Hsu-Cheng Huang, Chih-Ju Lin, Sheng-Lin Lee, Wei-Hsiang Wang, Vladimir A. Hovhannisyan, Yao-De Huang, Hsuan-Shu Lee, and Chen-Yuan Dong "In vivo multiphoton dynamic imaging of the hepatobiliary metabolism in chronic hepatic diseases", Proc. SPIE 10882, Multiphoton Microscopy in the Biomedical Sciences XIX, 108821B (22 February 2019); https://doi.org/10.1117/12.2507345
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Liver

Mode conditioning cables

In vivo imaging

Tumors

Pathology

Tumor growth modeling

Luminescence

Back to Top